The dawn of the four-drug era? SGLT2 inhibition in heart failure with reduced ejection fraction
{{output}}
Sodium-glucose cotransporter type 2 (SGLT2) inhibitors are a relatively new class of antihyperglycemic drug with salutary effects on glucose control, body weight, and blood pressure. Emerging evidence now indicates that these drugs may have a beneficial effect... ...
